Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke.
Kryukov AV, Sychev DA, Andreev DA, Ryzhikova KA, Grishina EA, Ryabova AV, Loskutnikov MA, Smirnov VV, Konova OD, Matsneva IA, Bochkov PO. Kryukov AV, et al. Among authors: bochkov po. Pharmgenomics Pers Med. 2018 Mar 22;11:43-49. doi: 10.2147/PGPM.S157111. eCollection 2018. Pharmgenomics Pers Med. 2018. PMID: 29606886 Free PMC article.
The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty.
Sychev DA, Levanov AN, Shelekhova TV, Bochkov PO, Denisenko NP, Ryzhikova KA, Mirzaev KB, Grishina EA, Gavrilov MA, Ramenskaya GV, Kozlov AV, Bogoslovsky T. Sychev DA, et al. Among authors: bochkov po. Pharmgenomics Pers Med. 2018 Jul 25;11:127-137. doi: 10.2147/PGPM.S169277. eCollection 2018. Pharmgenomics Pers Med. 2018. PMID: 30100750 Free PMC article.
Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease.
Sychev D, Skripka A, Ryzhikova K, Bochkov P, Shevchenko R, Krupenin P, Ivashchenko D, Kogay V, Listratov A, Krainyaya A, Gurinovich O, Sokolova A, Napalkov D, Fomin V. Sychev D, et al. Drug Metab Pers Ther. 2020 Mar 5;35(1):/j/dmdi.2020.35.issue-1/dmpt-2019-0029/dmpt-2019-0029.xml. doi: 10.1515/dmpt-2019-0029. Drug Metab Pers Ther. 2020. PMID: 32134727
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban.
Sychev DA, Baturina OA, Mirzaev KB, Rytkin E, Ivashchenko DV, Andreev DA, Ryzhikova KA, Grishina EA, Bochkov PO, Shevchenko RV. Sychev DA, et al. Among authors: bochkov po. Pharmgenomics Pers Med. 2020 Jan 23;13:29-37. doi: 10.2147/PGPM.S234910. eCollection 2020. Pharmgenomics Pers Med. 2020. PMID: 32158254 Free PMC article.
Drug-drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation.
Sychev D, Mirzaev K, Cherniaeva M, Kulikova M, Bochkov P, Shevchenko R, Gorbatenkova S, Golovina O, Ostroumova O, Bahteeva D, Rytkin E. Sychev D, et al. Drug Metab Pers Ther. 2020 Sep 4:/j/dmdi.ahead-of-print/dmdi-2020-0127/dmdi-2020-0127.xml. doi: 10.1515/dmdi-2020-0127. Online ahead of print. Drug Metab Pers Ther. 2020. PMID: 32887180
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Rytkin E, Bure IV, Bochkov PO, Akmalova KA, Mirzaev KB, Cherniaeva MS, Ostroumova OD, Smirnov VV, Grishina EA, Saribekian AG, Sychev IN, Sychev DA. Rytkin E, et al. Among authors: bochkov po. Drug Metab Pers Ther. 2021 Aug 13. doi: 10.1515/dmdi-2021-0118. Online ahead of print. Drug Metab Pers Ther. 2021. PMID: 34390638
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Rytkin E, Bure IV, Bochkov PO, Akmalova KA, Mirzaev KB, Cherniaeva MS, Ostroumova OD, Smirnov VV, Grishina EA, Saribekian AG, Sychev IN, Sychev DA. Rytkin E, et al. Among authors: bochkov po. Drug Metab Pers Ther. 2021 Aug 13;37(1):41-46. doi: 10.1515/dmpt-2021-0118. Drug Metab Pers Ther. 2021. PMID: 35385896
25 results